Canary Capital Amends Staked Injective ETF Filing with SEC

Canary Capital has amended its Staked Injective ETF filing with the US Securities and Exchange Commission (SEC), revealing significant changes to its prospectus. The issuer seeks to provide investors with regulated exposure to Injective and staking rewards through the ETF, which will track the CoinDesk Injective Benchmark Rate 60m NY Rate index.

The Canary Staked Injective ETF will be listed on Cboe BZX under the ticker INJS, with a minimum block size of 10,000 shares for buying or redeeming staked INJ. U.S. Bank NA is the cash custodian, while BitGo Bank & Trust will hold all of the trust's INJ.

Injective price has rebounded 5% to hit $8.6 in the last 24 hours, following a successful Meridian mainnet upgrade that added support for regulated tokenized assets and expanded INJ's role on the network.